NovaBay Pharmaceuticals A Ground Floor Opportunity, Analyst Expects 1350% Upside ($NBY)
NovaBay Pharmaceuticals Inc. (AMEX: NBY) stock is presenting a ground floor investment opportunity, so says an analyst at Ascendient Capital, who expects an over 1350% increase from current levels to $12 a share. That forecast isn’t blind ambition. The case is made after factoring in expected revenue increases, aggressive cost cutting, and faster market penetration
NovaBay Pharmaceuticals A Ground Floor Opportunity, Analyst Expects 1350% Upside ($NBY) Read More »

